HealthCor Catalio Acquisition Corp., a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced the pricing of its upsized initial public offering of 18,000,000 Class A ordinary shares at a price of $10.00 per share. The Company's sponsor is owned by affiliates of HealthCor Management, L.P., which manages approximately $2.7 billion in assets across long/short and long only healthcare funds, and Catalio Capital Management, LP, a private equity firm that invests in breakthrough biomedical technology companies. The Company will be led by Christopher Gaulin, as Chief Executive Officer, Joe Healey, as Chairman of the Board of Directors, and George Petrocheilos, as President. The Company will be listed on the Nasdaq Capital Market and trade under the ticker symbol "HCAQ" beginning on January 27, 2021.

Jefferies LLC is serving as sole book-running manager for this offering. The Company has granted the underwriter a 45-day option to purchase up to an additional 2,700,000 shares at the initial public offering price to cover over-allotments, if any.